论文信息 - Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey Models. - 字舞流文

Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey Models.

P. Brousset | P. Le Bouteiller | E. Jeunesse | H. Haegel | A. Bensussan | J. Giustiniani | V. Soler | T. Menguy | V. Duong | Alexandre Calcei | J. Mizrahi | Anne Briaux | I. Raymond Letron | T. Guyon